This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Journey of Taneisha Ann-Tanara Mack
Introduction:
Taneisha Ann-Tanara Mack, a visionary inventor based in East Hampton, CT, has left a significant mark in the world of biomedical innovation with his groundbreaking work in antibody-based therapeutics.
Latest Patents:
Mack's latest patents include "Humanized anti-CD200 antibodies and uses thereof," focusing on the treatment of cancer and organ transplantation using CD200-binding antibodies. Additionally, he pioneered "Monovalent anti-properdin antibodies and antibody fragments," targeting diseases mediated by alternative complement pathway dysregulation.
Career Highlights:
With a total of 2 patents to his name, Taneisha Ann-Tanara Mack has demonstrated exceptional expertise in the development of novel therapeutic antibodies. He is renowned for his meticulous approach to research and his commitment to advancing medical science.
Collaborations:
Mack's contributions have been strengthened by collaborations with esteemed colleagues such as Douglas L Sheridan and Paul P Tamburini. Together, they have pushed the boundaries of biomedical innovation and paved the way for new advancements in antibody-based treatments.
Conclusion:
In conclusion, Taneisha Ann-Tanara Mack's invaluable contributions to the field of biotechnology reflect his passion for improving healthcare outcomes and addressing unmet medical needs. His innovative spirit and collaborative efforts continue to inspire progress in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile